Lixte Biotech Hldgs Q1 EPS $(0.18) Up From $(0.29) YoY

Benzinga Newsdesk www.benzinga.com Negative 59.1%

Neg 59.1% Neu 0% Pos 0%

Lixte Biotech Hldgs (NASDAQ:LIXT) reported quarterly losses of $(0.18) per share. This is a 37.93 percent increase over losses of $(0.29) per share from the same period last year.